Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Pavement patterns can be designed to improve gait in Parkinson's disease patients.

Gál O, Poláková K, Hoskovcová M, Tomandl J, Čapek V, Berka R, Brožová H, Šestáková I, Růžička E.

Mov Disord. 2019 Aug 23. doi: 10.1002/mds.27831. [Epub ahead of print]

PMID:
31442358
2.

Author Correction: Air-stable superparamagnetic metal nanoparticles entrapped in graphene oxide matrix.

Tuček J, Sofer Z, Bouša D, Pumera M, Holá K, Malá A, Poláková K, Havrdová M, Čépe K, Tomanec O, Zbořil R.

Nat Commun. 2019 Jun 18;10(1):2696. doi: 10.1038/s41467-019-10702-2.

3.

Association of HLA-G Polymorphisms in the 3'UTR Region and Soluble HLA-G with Kidney Graft Outcome.

Durmanova V, Bandzuchova H, Zilinska Z, Tirpakova J, Kuba D, Buc M, Polakova K.

Immunol Invest. 2019 Aug;48(6):644-658. doi: 10.1080/08820139.2019.1610888. Epub 2019 May 16.

PMID:
31094243
4.

Methanol Poisoning as an Acute Toxicological Basal Ganglia Lesion Model: Evidence from Brain Volumetry and Cognition.

Mana J, Vaneckova M, Klempíř J, Lišková I, Brožová H, Poláková K, Seidl Z, Miovský M, Pelclová D, Bukačová K, Maréchal B, Kober T, Zakharov S, Růžička E, Bezdicek O.

Alcohol Clin Exp Res. 2019 Jul;43(7):1486-1497. doi: 10.1111/acer.14077. Epub 2019 May 28. Review.

PMID:
31074872
5.

The Effect of Rhodamine-Derived Superparamagnetic Maghemite Nanoparticles on the Motility of Human Mesenchymal Stem Cells and Mouse Embryonic Fibroblast Cells.

Baiazitova L, Skopalik J, Chmelik J, Zumberg I, Cmiel V, Polakova K, Provaznik I.

Molecules. 2019 Mar 27;24(7). pii: E1192. doi: 10.3390/molecules24071192.

6.

Flow induced HeLa cell detachment kinetics show that oxygen-containing functional groups in graphene oxide are potent cell adhesion enhancers.

Vlček J, Lapčík L, Havrdová M, Poláková K, Lapčíková B, Opletal T, Froning JP, Otyepka M.

Nanoscale. 2019 Feb 14;11(7):3222-3228. doi: 10.1039/c8nr08994a.

PMID:
30706925
7.

Comparison of HLA-G and MMP transcription in human tumor cell lines.

Polakova K, Bandzuchova E.

Neoplasma. 2018 Nov 15;65(6):943-951. doi: 10.4149/neo_2018_180409N230. Epub 2018 Sep 4.

PMID:
30334453
8.

A unique de novo gain-of-function variant in CAMK4 associated with intellectual disability and hyperkinetic movement disorder.

Zech M, Lam DD, Weber S, Berutti R, Poláková K, Havránková P, Fečíková A, Strom TM, Růžička E, Jech R, Winkelmann J.

Cold Spring Harb Mol Case Stud. 2018 Dec 17;4(6). pii: a003293. doi: 10.1101/mcs.a003293. Print 2018 Dec.

9.

Carbon Dot Fluorescence-Lifetime-Encoded Anti-Counterfeiting.

Kalytchuk S, Wang Y, Poláková K, Zbořil R.

ACS Appl Mater Interfaces. 2018 Sep 5;10(35):29902-29908. doi: 10.1021/acsami.8b11663. Epub 2018 Aug 21.

PMID:
30085654
10.

BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia.

Srutova K, Curik N, Burda P, Savvulidi F, Silvestri G, Trotta R, Klamova H, Pecherkova P, Sovova Z, Koblihova J, Stopka T, Perrotti D, Polakova KM.

Haematologica. 2018 Dec;103(12):2016-2025. doi: 10.3324/haematol.2018.193086. Epub 2018 Jul 26.

11.

Cyanographene and Graphene Acid: Emerging Derivatives Enabling High-Yield and Selective Functionalization of Graphene.

Bakandritsos A, Pykal M, Błoński P, Jakubec P, Chronopoulos DD, Poláková K, Georgakilas V, Čépe K, Tomanec O, Ranc V, Bourlinos AB, Zbořil R, Otyepka M.

ACS Nano. 2017 Mar 28;11(3):2982-2991. doi: 10.1021/acsnano.6b08449. Epub 2017 Feb 20.

12.

Carbon Dot Nanothermometry: Intracellular Photoluminescence Lifetime Thermal Sensing.

Kalytchuk S, Poláková K, Wang Y, Froning JP, Cepe K, Rogach AL, Zbořil R.

ACS Nano. 2017 Feb 28;11(2):1432-1442. doi: 10.1021/acsnano.6b06670. Epub 2017 Jan 31.

PMID:
28125202
13.

Microscale magnetic microparticle-based immunopurification of cytokinins from Arabidopsis root apex.

Plačková L, Oklestkova J, Pospíšková K, Poláková K, Buček J, Stýskala J, Zatloukal M, Šafařík I, Zbořil R, Strnad M, Doležal K, Novák O.

Plant J. 2017 Mar;89(5):1065-1075. doi: 10.1111/tpj.13443. Epub 2017 Feb 20.

14.

Rhodamine bound maghemite as a long-term dual imaging nanoprobe of adipose tissue-derived mesenchymal stromal cells.

Cmiel V, Skopalik J, Polakova K, Solar J, Havrdova M, Milde D, Justan I, Magro M, Starcuk Z, Provaznik I.

Eur Biophys J. 2017 Jul;46(5):433-444. doi: 10.1007/s00249-016-1187-1. Epub 2016 Nov 26.

PMID:
27889810
15.

Expression of genes encoding centrosomal proteins and the humoral response against these proteins in chronic myeloid leukemia.

Šmahelová J, Kaštánková I, Poláková KM, Klamová H, Zemanová K, Tachezy R, Hamšíková E, Šmahel M.

Oncol Rep. 2017 Jan;37(1):547-554. doi: 10.3892/or.2016.5226. Epub 2016 Nov 7.

PMID:
27840977
16.

Magnetic resonance cholangiopancreatography (MRCP) using new negative per-oral contrast agent based on superparamagnetic iron oxide nanoparticles for extrahepatic biliary duct visualization in liver cirrhosis.

Polakova K, Mocikova I, Purova D, Tucek P, Novak P, Novotna K, Izak N, Bielik R, Zboril R, Miroslav H.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Dec;160(4):512-517. doi: 10.5507/bp.2016.046. Epub 2016 Sep 15.

17.

Air-stable superparamagnetic metal nanoparticles entrapped in graphene oxide matrix.

Tuček J, Sofer Z, Bouša D, Pumera M, Holá K, Malá A, Poláková K, Havrdová M, Čépe K, Tomanec O, Zbořil R.

Nat Commun. 2016 Sep 15;7:12879. doi: 10.1038/ncomms12879. Erratum in: Nat Commun. 2019 Jun 18;10(1):2696.

18.

Proteomic analysis of imatinib-resistant CML-T1 cells reveals calcium homeostasis as a potential therapeutic target.

Toman O, Kabickova T, Vit O, Fiser R, Polakova KM, Zach J, Linhartova J, Vyoral D, Petrak J.

Oncol Rep. 2016 Sep;36(3):1258-68. doi: 10.3892/or.2016.4945. Epub 2016 Jul 18.

19.

Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients.

Soverini S, De Benedittis C, Polakova KM, Linhartova J, Castagnetti F, Gugliotta G, Papayannidis C, Mancini M, Klamova H, Salvucci M, Crugnola M, Iurlo A, Albano F, Russo D, Rosti G, Cavo M, Baccarani M, Martinelli G.

Oncotarget. 2016 Apr 19;7(16):21982-90. doi: 10.18632/oncotarget.8010.

20.

Clinical impact of low-burden BCR-ABL1 mutations detectable by amplicon deep sequencing in Philadelphia-positive acute lymphoblastic leukemia patients.

Soverini S, De Benedittis C, Papayannidis C, Polakova KM, Venturi C, Russo D, Bresciani P, Iurlo A, Mancini M, Vitale A, Chiaretti S, Foà R, Abruzzese E, Sorà F, Kohlmann A, Haferlach T, Baccarani M, Cavo M, Martinelli G.

Leukemia. 2016 Jul;30(7):1615-9. doi: 10.1038/leu.2016.17. Epub 2016 Feb 12. No abstract available.

PMID:
26867670
21.

Expression of HLA-G transcripts in graft biopsy samples of renal transplant recipients.

Žilinská Z, Bandžuchová H, Chrastina M, Trebatický B, Breza J Sr, Handzušová M, Kuba D, Tirpáková J, Pavlechová M, Dedinská I, Rychlý B, Poláková K.

Transpl Immunol. 2015 Nov;33(3):159-65. doi: 10.1016/j.trim.2015.10.001. Epub 2015 Oct 9.

PMID:
26455418
22.

A dermocosmetic containing bakuchiol, Ginkgo biloba extract and mannitol improves the efficacy of adapalene in patients with acne vulgaris: result from a controlled randomized trial.

Poláková K, Fauger A, Sayag M, Jourdan E.

Clin Cosmet Investig Dermatol. 2015 Apr 10;8:187-91. doi: 10.2147/CCID.S81691. eCollection 2015.

23.

Genetically engineered mesenchymal stromal cells producing TNFα have tumour suppressing effect on human melanoma xenograft.

Tyciakova S, Matuskova M, Bohovic R, Polakova K, Toro L, Skolekova S, Kucerova L.

J Gene Med. 2015 Jan-Feb;17(1-2):54-67. doi: 10.1002/jgm.2823.

PMID:
25677845
24.

In vitro cytotoxicity analysis of doxorubicin-loaded/superparamagnetic iron oxide colloidal nanoassemblies on MCF7 and NIH3T3 cell lines.

Tomankova K, Polakova K, Pizova K, Binder S, Havrdova M, Kolarova M, Kriegova E, Zapletalova J, Malina L, Horakova J, Malohlava J, Kolokithas-Ntoukas A, Bakandritsos A, Kolarova H, Zboril R.

Int J Nanomedicine. 2015 Jan 29;10:949-61. doi: 10.2147/IJN.S72590. eCollection 2015.

25.

Mesenchymal stromal cell labeling by new uncoated superparamagnetic maghemite nanoparticles in comparison with commercial Resovist--an initial in vitro study.

Skopalik J, Polakova K, Havrdova M, Justan I, Magro M, Milde D, Knopfova L, Smarda J, Polakova H, Gabrielova E, Vianello F, Michalek J, Zboril R.

Int J Nanomedicine. 2014 Nov 20;9:5355-72. doi: 10.2147/IJN.S66986. eCollection 2014.

26.

Analysis of HLA-G expression in serum and biopsy samples of kidney transplant recipients.

Poláková K, Bandžuchová H, Žilinská Z, Chreňová S, Kuba D, Russ G.

Immunobiology. 2015 Apr;220(4):533-7. doi: 10.1016/j.imbio.2014.10.017. Epub 2014 Oct 28.

PMID:
25468563
27.

Field emission scanning electron microscopy (FE-SEM) as an approach for nanoparticle detection inside cells.

Havrdova M, Polakova K, Skopalik J, Vujtek M, Mokdad A, Homolkova M, Tucek J, Nebesarova J, Zboril R.

Micron. 2014 Dec;67:149-154. doi: 10.1016/j.micron.2014.08.001. Epub 2014 Aug 13.

PMID:
25173605
28.

A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR.

White H, Deprez L, Corbisier P, Hall V, Lin F, Mazoua S, Trapmann S, Aggerholm A, Andrikovics H, Akiki S, Barbany G, Boeckx N, Bench A, Catherwood M, Cayuela JM, Chudleigh S, Clench T, Colomer D, Daraio F, Dulucq S, Farrugia J, Fletcher L, Foroni L, Ganderton R, Gerrard G, Gineikienė E, Hayette S, El Housni H, Izzo B, Jansson M, Johnels P, Jurcek T, Kairisto V, Kizilors A, Kim DW, Lange T, Lion T, Polakova KM, Martinelli G, McCarron S, Merle PA, Milner B, Mitterbauer-Hohendanner G, Nagar M, Nickless G, Nomdedéu J, Nymoen DA, Leibundgut EO, Ozbek U, Pajič T, Pfeifer H, Preudhomme C, Raudsepp K, Romeo G, Sacha T, Talmaci R, Touloumenidou T, Van der Velden VH, Waits P, Wang L, Wilkinson E, Wilson G, Wren D, Zadro R, Ziermann J, Zoi K, Müller MC, Hochhaus A, Schimmel H, Cross NC, Emons H.

Leukemia. 2015 Feb;29(2):369-76. doi: 10.1038/leu.2014.217. Epub 2014 Jul 18.

29.

Core-shell hybrid nanomaterial based on prussian blue and surface active maghemite nanoparticles as stable electrocatalyst.

Magro M, Baratella D, Salviulo G, Polakova K, Zoppellaro G, Tucek J, Kaslik J, Zboril R, Vianello F.

Biosens Bioelectron. 2014 Feb 15;52:159-65. doi: 10.1016/j.bios.2013.08.052. Epub 2013 Aug 30.

PMID:
24041662
30.

No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia.

Racil Z, Razga F, Klamova H, Voglova J, Belohlavkova P, Malaskova L, Potesil D, Muzik J, Zackova D, Polakova KM, Zdrahal Z, Malakova J, Suttnar J, Dyr J, Mayer J.

Hematol Oncol. 2014 Jun;32(2):87-93. doi: 10.1002/hon.2091. Epub 2013 Aug 20. Erratum in: Hematol Oncol. 2014 Sep;32(3):168.

PMID:
23963760
31.

Recent patterns in cutaneous melanoma descriptive epidemiology in the Slovak Republic.

Ondrusova M, Mrinakova B, Ondrus D, Polakova K, Durdik S.

Neoplasma. 2013;60(6):706-13. doi: 10.4149/neo_2013_090.

PMID:
23906306
32.

Evaluation of 5-year imatinib treatment of 458 patients with CP-CML in routine clinical practice and prognostic impact of different BCR-ABL cutoff levels.

Klamová H, Poláková KM, Mužík J, Ráčil Z, Záčková D, Steinerová K, Karas M, Faber E, Demečková E, Michalovičová-Sninská Z, Voglová J, Demitrovičová L, Mikušková E, Tóthová E, Chudej J, Markuljak I, Cmunt E, Moravcová J, Dvořáková D, Michalová K, Jarošová M, Sťastná MM, Cetkovský P, Dušek L, Koza V, Trněný M, Indrák K.

Cancer Med. 2013 Apr;2(2):216-25. doi: 10.1002/cam4.59. Epub 2013 Feb 21.

33.

Thermostable trypsin conjugates immobilized to biogenic magnetite show a high operational stability and remarkable reusability for protein digestion.

Pečová M, Šebela M, Marková Z, Poláková K, Čuda J, Šafářová K, Zbořil R.

Nanotechnology. 2013 Mar 29;24(12):125102. doi: 10.1088/0957-4484/24/12/125102. Epub 2013 Mar 6.

PMID:
23466477
34.

HLA-G5 in the blood of leukemia patients and healthy individuals.

Poláková K, Železníková T, Russ G.

Leuk Res. 2013 Feb;37(2):139-45. doi: 10.1016/j.leukres.2012.10.019. Epub 2012 Nov 10.

PMID:
23146557
35.

Surface design of core-shell superparamagnetic iron oxide nanoparticles drives record relaxivity values in functional MRI contrast agents.

Maity D, Zoppellaro G, Sedenkova V, Tucek J, Safarova K, Polakova K, Tomankova K, Diwoky C, Stollberger R, Machala L, Zboril R.

Chem Commun (Camb). 2012 Dec 4;48(93):11398-400. doi: 10.1039/c2cc35515a. Epub 2012 Oct 12.

PMID:
23066527
36.

MR enterography with a new negative oral contrast solution containing maghemite nanoparticles.

Markova I, Polakova K, Tucek P, Mashlan M, Novak P, Zboril R, Herman M.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2012 Sep;156(3):229-35. doi: 10.5507/bp.2012.001. Epub 2012 Jan 30.

37.

Charge binding of rhodamine derivative to OH- stabilized nanomaghemite: universal nanocarrier for construction of magnetofluorescent biosensors.

Magro M, Sinigaglia G, Nodari L, Tucek J, Polakova K, Marusak Z, Cardillo S, Salviulo G, Russo U, Stevanato R, Zboril R, Vianello F.

Acta Biomater. 2012 Jul;8(6):2068-76. doi: 10.1016/j.actbio.2012.02.005. Epub 2012 Feb 13.

PMID:
22342825
38.

A DNA vaccine expressing PB1 protein of influenza A virus protects mice against virus infection.

Košík I, Krejnusová I, Práznovská M, Poláková K, Russ G.

Arch Virol. 2012 May;157(5):811-7. doi: 10.1007/s00705-012-1238-6.

PMID:
22294447
39.

Impact of blood processing on estimation of soluble HLA-G.

Poláková K, Bandžuchová E, Russ G.

Neoplasma. 2011;58(4):337-42.

PMID:
21520991
40.

N-terminal region of the PB1-F2 protein is responsible for increased expression of influenza A viral protein PB1.

Košík I, Krejnusová I, Bystrická M, Poláková K, Russ G.

Acta Virol. 2011;55(1):45-53.

PMID:
21434704
41.

Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: can we compare real life data to the results from clinical trials?

Zackova D, Klamova H, Dusek L, Muzik J, Polakova KM, Moravcova J, Jurcek T, Dvorakova D, Racil Z, Pospisil Z, Oltova A, Michalova K, Brezinova J, Razga F, Doubek M, Cetkovsky P, Trneny M, Mayer J.

Am J Hematol. 2011 Mar;86(3):318-21. doi: 10.1002/ajh.21942. Epub 2011 Feb 15. No abstract available.

42.

Assessment of adenosine triphosphate-binding cassette subfamily B member 1 (ABCB1) mRNA expression in patients with de novo chronic myelogenous leukemia: the role of different cell types.

Racil Z, Razga F, Polakova KM, Buresova L, Polivkova V, Dvorakova D, Zackova D, Klamova H, Cetkovsky P, Mayer J.

Leuk Lymphoma. 2011 Feb;52(2):331-4. doi: 10.3109/10428194.2010.533220. Epub 2010 Dec 6. No abstract available.

PMID:
21133723
43.

Constant BCR-ABL transcript level >or=0.1% (IS) in patients with CML responding to imatinib with complete cytogenetic remission may indicate mutation analysis.

Poláková KM, Polívková V, Rulcová J, Klamová H, Jurcek T, Dvoráková D, Zácková D, Pospísil Z, Mayer J, Moravcová J.

Exp Hematol. 2010 Jan;38(1):20-6. doi: 10.1016/j.exphem.2009.10.003.

PMID:
19837125
44.

Activation of HLA-G expression by 5-aza-2 - deoxycytidine in malignant hematopoetic cells isolated from leukemia patients.

Polakova K, Bandzuchova E, Sabty FA, Mistrik M, Demitrovicova L, Russ G.

Neoplasma. 2009;56(6):514-20.

PMID:
19728760
45.

Antibodies to PB1-F2 protein are induced in response to influenza A virus infection.

Krejnusová I, Gocníková H, Bystrická M, Blaskovicová H, Poláková K, Yewdell J, Bennink J, Russ G.

Arch Virol. 2009;154(10):1599-604. doi: 10.1007/s00705-009-0479-5. Epub 2009 Aug 12.

46.

Demethylating agent 5-aza-2'-deoxycytidine activates HLA-G expression in human leukemia cell lines.

Poláková K, Bandzuchová E, Kuba D, Russ G.

Leuk Res. 2009 Apr;33(4):518-24. doi: 10.1016/j.leukres.2008.08.003. Epub 2008 Sep 26.

PMID:
18823661
47.

Control genes in international standardization of real-time RT-PCR for BCR-ABL.

Moravcová J, Rulcová J, Poláková KM, Klamová H.

Leuk Res. 2009 Apr;33(4):582-4. doi: 10.1016/j.leukres.2008.06.020. Epub 2008 Jul 23. No abstract available.

PMID:
18653236
48.

BCR-ABL mutations in chronic myeloid leukemia - not only detection.

Polakova KM, Zmekova V, Rulcova J, Klamova H, Zemanova Z, Moravcova J.

Leuk Lymphoma. 2008 Aug;49(8):1620-2. doi: 10.1080/10428190802105074. No abstract available.

PMID:
18452092
49.

High-resolution melt curve analysis: initial screening for mutations in BCR-ABL kinase domain.

Poláková KM, Lopotová T, Klamová H, Moravcová J.

Leuk Res. 2008 Aug;32(8):1236-43. doi: 10.1016/j.leukres.2008.01.010. Epub 2008 Mar 4.

PMID:
18308387
50.

Modulation of HLA-G expression.

Polakova K, Bandzuchova E, Tirpakova J, Kuba D, Russ G.

Neoplasma. 2007;54(6):455-62.

PMID:
17949227

Supplemental Content

Loading ...
Support Center